{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:12:18Z","timestamp":1782803538052,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000938","name":"Robert E. Leet and Clara Guthrie Patterson Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.puhe.2019.08.010","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T04:45:45Z","timestamp":1572842745000},"page":"137-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis"],"prefix":"10.1016","volume":"178","author":[{"given":"L.R.","family":"Avni-Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Yakely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.S.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Niccolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1897-6581","authenticated-orcid":false,"given":"C.R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2019.08.010_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates","volume":"40","author":"Satterwhite","year":"2008","journal-title":"Sex Transm Dis. 2013"},{"key":"10.1016\/j.puhe.2019.08.010_bib2","series-title":"Prevalence of HPV in adults aged 18-69: United States, 2011-2014. NCHS Data Brief","first-page":"1","author":"McQuillan","year":"2017"},{"key":"10.1016\/j.puhe.2019.08.010_bib3","first-page":"7","article-title":"Cancer statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.puhe.2019.08.010_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/sextrans-2014-051754","article-title":"Psychological effects of diagnosis and treatment of cervical intraepithelial neoplasia: a systematic review","volume":"91","author":"Frederiksen","year":"2015","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.puhe.2019.08.010_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2019.08.010_bib6","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.puhe.2019.08.010_bib7","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1080\/21645515.2017.1346755","article-title":"Expanded strain coverage for a highly successful public health tool: prophylactic 9-valent human papillomavirus vaccine","volume":"13","author":"Zhang","year":"2017","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.puhe.2019.08.010_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2019.08.010_bib9","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/1055-9965.EPI-14-0410","article-title":"Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease","volume":"23","author":"Joura","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.puhe.2019.08.010_bib10","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1016\/j.vaccine.2013.07.006","article-title":"Vaccine effects and impact of vaccination programmes in post-licensure studies","volume":"31","author":"Hanquet","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2019.08.010_bib11","doi-asserted-by":"crossref","first-page":"2819372","DOI":"10.1155\/2017\/2819372","article-title":"Socioeconomic and racial\/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities","volume":"2017","author":"Singh","year":"2017","journal-title":"J Environ Public Health"},{"issue":"Suppl 7","key":"10.1016\/j.puhe.2019.08.010_bib12","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/cncr.28569","article-title":"An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual","volume":"120","author":"Vickers","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.puhe.2019.08.010_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1353\/ken.0.0121","article-title":"Women and health research: a report from the Institute of Medicine","volume":"4","author":"Mastroianni","year":"1994","journal-title":"Kennedy Inst Ethics J"},{"key":"10.1016\/j.puhe.2019.08.010_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1089\/heq.2017.0015","article-title":"Primary care physicians' collection, comfort, and use of race and ethnicity in clinical practice in the United States","volume":"1","author":"Bonham","year":"2017","journal-title":"Health Equity"},{"key":"10.1016\/j.puhe.2019.08.010_bib15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jclinepi.2006.11.009","article-title":"Systematic review identified suboptimal reporting and use of race\/ethnicity in general medical journals","volume":"60","author":"Ma","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.puhe.2019.08.010_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.puhe.2019.08.010_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000452240","article-title":"Racial\/ethnic disparities in cervical cancer screening and outcomes","volume":"60","author":"Musselwhite","year":"2016","journal-title":"Acta Cytol"},{"key":"10.1016\/j.puhe.2019.08.010_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fpubh.2015.00256","article-title":"Health disparities in the immunoprevention of human papillomavirus infection and associated malignancies","volume":"3","author":"Bakir","year":"2015","journal-title":"Front Public Health"},{"key":"10.1016\/j.puhe.2019.08.010_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinthera.2013.11.001","article-title":"Race, ethnicity, and income factors impacting human papillomavirus vaccination rates","volume":"36","author":"Jeudin","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.puhe.2019.08.010_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.puhe.2019.08.010_bib21","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1542\/peds.2011-3587","article-title":"Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction","volume":"130","author":"Kahn","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.puhe.2019.08.010_bib22","first-page":"5","article-title":"Sexually transmitted infections, active component, U.S. Armed Forces, 2000-2012","volume":"20","author":"Center","year":"2013","journal-title":"MSMR"},{"key":"10.1016\/j.puhe.2019.08.010_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010","volume":"208","author":"Markowitz","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2019.08.010_bib24","first-page":"e194","article-title":"Surveillance of human papilloma virus using reference laboratory data for the purpose of evaluating vaccine impact","volume":"6","author":"Wilson","year":"2014","journal-title":"Online J Public Health Inform"},{"key":"10.1016\/j.puhe.2019.08.010_bib25","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1017\/S0950268814001538","article-title":"Recent trends in type-specific HPV infection rates in the United States","volume":"143","author":"Dickson","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.puhe.2019.08.010_bib26","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/infdis\/jiv342","article-title":"Reduction in human papillomavirus vaccine type prevalence among young women screened for cervical cancer in an integrated US healthcare delivery system in 2007 and 2012-2013","volume":"212","author":"Dunne","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2019.08.010_bib27","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/infdis\/jiw515","article-title":"Reduction in vaccine-type human papillomavirus prevalence among women in the United States, 2009-2012","volume":"214","author":"Berenson","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2019.08.010_bib28","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1968","article-title":"Prevalence of HPV after introduction of the vaccination program in the United States","volume":"137","author":"Markowitz","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.puhe.2019.08.010_bib29","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/AOG.0000000000001760","article-title":"Prevalence of human papillomavirus in self-collected cervicovaginal swabs in young women in the United States between 2003 and 2012","volume":"128","author":"Tarney","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.puhe.2019.08.010_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/AOG.0000000000002193","article-title":"Change in human papillomavirus prevalence among U.S. Women aged 18-59 Years, 2009-2014","volume":"130","author":"Berenson","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.puhe.2019.08.010_bib31","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/infdis\/jix244","article-title":"Prevalence of human papillomavirus among females after vaccine introduction-national health and nutrition examination survey, United States, 2003-2014","volume":"216","author":"Oliver","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2019.08.010_bib32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010","volume":"102","author":"Bauer","year":"2012","journal-title":"Am J Public Health"},{"key":"10.1016\/j.puhe.2019.08.010_bib33","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination","volume":"103","author":"Flagg","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.puhe.2019.08.010_bib34","first-page":"17","article-title":"Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine","volume":"20","author":"Nsouli-Maktabi","year":"2013","journal-title":"MSMR"},{"key":"10.1016\/j.puhe.2019.08.010_bib35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/OLQ.0000000000000369","article-title":"Trends in male and female genital warts among adolescents in a safety-net health care system 2004-2013: correlation with introduction of female and male human papillomavirus vaccination","volume":"42","author":"Perkins","year":"2015","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2019.08.010_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2105\/AJPH.2017.304119","article-title":"Declines in anogenital warts among age groups most likely to Be impacted by human papillomavirus vaccination, United States, 2006-2014","volume":"108","author":"Flagg","year":"2018","journal-title":"Am J Public Health"},{"key":"10.1016\/j.puhe.2019.08.010_bib37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaoncol.2016.3609","article-title":"Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era","volume":"3","author":"Benard","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.puhe.2019.08.010_bib38","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1158\/1055-9965.EPI-13-0272","article-title":"Declining rates of high-grade cervical lesions in young women in Connecticut, 2008-2011","volume":"22","author":"Niccolai","year":"2013","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.puhe.2019.08.010_bib39","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cncr.29266","article-title":"Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States","volume":"121","author":"Hariri","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.puhe.2019.08.010_bib40","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.vaccine.2015.01.084","article-title":"Reduction in HPV 16\/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012","volume":"33","author":"Hariri","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2019.08.010_bib41","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2105\/AJPH.2016.303472","article-title":"Ecological association of human papillomavirus vaccination with cervical dysplasia prevalence in the United States, 2007-2014","volume":"106","author":"Flagg","year":"2016","journal-title":"Am J Public Health"},{"key":"10.1016\/j.puhe.2019.08.010_bib42","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/cid\/cix455","article-title":"Declines in human papillomavirus (HPV)-Associated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, United States, 2008-2015","volume":"65","author":"Niccolai","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2019.08.010_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ypmed.2017.07.027","article-title":"Surveillance of high-grade cervical cancer precursors (CIN III\/AIS) in four population-based cancer registries, United States, 2009-2012","volume":"103","author":"Watson","year":"2017","journal-title":"Prev Med"},{"key":"10.1016\/j.puhe.2019.08.010_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.AOG.0000266984.23445.9c","article-title":"Sociodemographic factors associated with high-risk human papillomavirus infection","volume":"110","author":"Kahn","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.puhe.2019.08.010_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","author":"Jemal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.puhe.2019.08.010_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1377\/hlthaff.28.1.160","article-title":"A matter of race: early-versus late-stage cancer diagnosis","volume":"28","author":"Virnig","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.puhe.2019.08.010_bib47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jnci\/djs638","article-title":"Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination","volume":"105","author":"Brisson","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.puhe.2019.08.010_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jech-2011-200520","article-title":"Residential racial segregation and racial differences in sexual behaviours: an 11-year longitudinal study of sexual risk of adolescents transitioning to adulthood","volume":"67","author":"Biello","year":"2013","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.puhe.2019.08.010_bib49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 Years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2019.08.010_bib50","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.pcl.2009.09.006","article-title":"Vaccine preventable diseases and vaccination policy for indigenous populations","volume":"56","author":"Menzies","year":"2009","journal-title":"Pediatr Clin N Am"},{"key":"10.1016\/j.puhe.2019.08.010_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1037\/0003-066X.49.1.15","article-title":"Socioeconomic status and health. The challenge of the gradient","volume":"49","author":"Adler","year":"1994","journal-title":"Am Psychol"},{"key":"10.1016\/j.puhe.2019.08.010_bib52","first-page":"4","article-title":"The use of race and ethnicity in public health surveillance","volume":"109","author":"Warren","year":"1994","journal-title":"Public Health Rep"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350619302689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350619302689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:31:57Z","timestamp":1758501117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350619302689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":52,"alternative-id":["S0033350619302689"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2019.08.010","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2019.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}